Roderike Pohl
Keine laufenden Positionen mehr
Profil
Roderike Pohl was Vice President-Research for Biodel, Inc. from December 2003 to December 13, 2008.
He was a Scientific Consultant for Steiner Ventures LLC from August 2003 to November 2003.
Dr. Pohl was Vice President of Preclinical Research MannKind Corporation from December 1998 to July 2003.
He received a PhD from the University of Connecticut.
Ehemalige bekannte Positionen von Roderike Pohl
Unternehmen | Position | Ende |
---|---|---|
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Technik-/Wissenschafts-/F&E-Leiter | 13.12.2008 |
Pharmaceutical Discovery Corp. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2003 |
Ausbildung von Roderike Pohl
University of Connecticut | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Health Technology |
Pharmaceutical Discovery Corp. | Health Technology |